Company

UTILITY therapeutics, Ltd.

UTILITY therapeutics develops antibiotics for urinary tract infections.

About

UTILITY therapeutics develops antibiotics for urinary tract infections, including oral pivmecillinam and IV mecillinam. Founded in 2017 by Morten Sommer and Rasmus Toft-Kehler, the company is based in Cheshire, UK. Alembic Technologies, a portfolio company of KB Partners, OCA Ventures, Ridge Ventures, IrishAngels, Liquid 2 Ventures, WndrCo, and Village Global, acquired it from AMR Action Fund in July 2025 for USD 12 million. Tom Hadley is the CEO.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in